Gopinath Gnanasegaran

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

PET/CT in acute and time-sensitive non-oncological conditions: Current evidence, clinical applications, and emerging roles.

PET/CT in acute and time-sensitive non-oncological conditions: Current evidence, clinical applications, and emerging roles.

Journal: Seminars in nuclear medicine

Published: August 12, 2026

Impact of peptide receptor radionuclide therapy (PRRT) on the quality of life in patients with neuroendocrine tumours.

Impact of peptide receptor radionuclide therapy (PRRT) on the quality of life in patients with neuroendocrine tumours.

Journal: Journal of neuroendocrinology

Published: March 24, 2026

Radiolabeled fibroblast activation protein inhibitor PET/computed tomography imaging in invasive lobular breast cancer: a narrative review and research agenda.

Radiolabeled fibroblast activation protein inhibitor PET/computed tomography imaging in invasive lobular breast cancer: a narrative review and research agenda.

Journal: Nuclear medicine communications

Published: February 26, 2026

Fluorine-18 fluorodeoxyglucose PET/computed tomography-based scoring systems in oncology: pictorial review from clinical practice.

Fluorine-18 fluorodeoxyglucose PET/computed tomography-based scoring systems in oncology: pictorial review from clinical practice.

Journal: Nuclear medicine communications

Published: January 26, 2026

Radiolabeled fibroblast activation protein inhibitor PET/computed tomography imaging in invasive lobular breast cancer: a narrative review and research agenda.

Radiolabeled fibroblast activation protein inhibitor PET/computed tomography imaging in invasive lobular breast cancer: a narrative review and research agenda.

Journal: Nuclear medicine communications

Published: November 24, 2025

⁶⁸GA-Pentixafor PET/CT: a non-invasive molecular alternative to adrenal venous sampling in primary aldosteronism.

⁶⁸GA-Pentixafor PET/CT: a non-invasive molecular alternative to adrenal venous sampling in primary aldosteronism.

Journal: EJNMMI reports

Published: November 08, 2025

68Ga-DOTA-TATE PET/CT improves accuracy and guides management in multiple endocrine neoplasia type 1 (MEN-1) patients with suspected duodeno-pancreatic neuroendocrine tumours.

68Ga-DOTA-TATE PET/CT improves accuracy and guides management in multiple endocrine neoplasia type 1 (MEN-1) patients with suspected duodeno-pancreatic neuroendocrine tumours.

Journal: Endocrine oncology (Bristol, England)

Published: June 07, 2025

Lymphatic mapping Of Oropharyngeal Cancer (LOOC): protocol for a phase II surgical imaging trial to evaluate contralateral drainage and occult metastasis in oropharyngeal cancer.

Lymphatic mapping Of Oropharyngeal Cancer (LOOC): protocol for a phase II surgical imaging trial to evaluate contralateral drainage and occult metastasis in oropharyngeal cancer.

Journal: BMJ open

Published: June 05, 2025

Theranostics in Perspective: White Paper.

Theranostics in Perspective: White Paper.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 25, 2025

177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence.

177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence.

Journal: Endocrine oncology (Bristol, England)

Published: February 22, 2025

α v β 6 Imaging With 68 Ga-Trivehexin PET/CT in Pituitary Macroadenoma.

α v β 6 Imaging With 68 Ga-Trivehexin PET/CT in Pituitary Macroadenoma.

Journal: Clinical nuclear medicine

Published: January 23, 2025

Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas.

Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas.

Journal: Endocrine oncology (Bristol, England)

Published: December 22, 2024

Showing 1-12 of 110

Last Updated: 09/26/2026